Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Solomon

Showing results (81-90 of 621) with videos related to

Pageof 63
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|February 5, 2026
Big Data May Have Big Pitfalls: Ensuring Rigor in Rheumatic Disease EpidemiologyKaren H Costenbader, Daniel H Solomon, S Louis Bridges
The Journal of Rheumatology|June 7, 2006
The patient's perspective on the recall of VioxxGillian A Hawker, Jeffrey N Katz, Daniel H Solomon
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2017
Editorial: Tumor Necrosis Factor Antagonists: Killing Two Birds With One Biologic StoneJoan M Bathon, Jon T Giles, Daniel H Solomon
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Editorial: the vital role of randomized controlled trials in Arthritis & RheumatologyDaniel H Solomon, Michael E Weinblatt, Richard J Bucala
Rheumatology (Oxford, England)|December 23, 2019
Comment on: Comorbidity burden in axial spondyloarthritis: a cluster analysis: replySizheng Steven Zhao, Daniel H Solomon, Nicola J Goodson
Rheumatology (Oxford, England)|September 11, 2019
Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trialsKathleen M M Vanni, Houchen Lyu, Daniel H Solomon
Rheumatology International|April 19, 2018
Pseudogout among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition DiseaseSara K Tedeschi, Daniel H Solomon, Katherine P Liao
Arthritis Care & Research|June 1, 2019
Low-Dose Methotrexate and Mucocutaneous Adverse Events: Results of a Systematic Literature Review and Meta-Analysis of Randomized Controlled TrialsRiyana Lalani, Houchen Lyu, Kathleen Vanni, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 2004
Relationship between COX-2 specific inhibitors and hypertensionDaniel H Solomon, Sebastian Schneeweiss, Raisa Levin, et al.
Arthritis Care & Research|July 18, 2013
Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalinSeoyoung C Kim, Joan E Landon, Daniel H Solomon
Pageof 63

Showing results (81-90 of 621) with videos related to

Sort By:
Pageof 63
Arthritis & Rheumatology (Hoboken, N.J.)|February 5, 2026
Big Data May Have Big Pitfalls: Ensuring Rigor in Rheumatic Disease EpidemiologyKaren H Costenbader, Daniel H Solomon, S Louis Bridges
The Journal of Rheumatology|June 7, 2006
The patient's perspective on the recall of VioxxGillian A Hawker, Jeffrey N Katz, Daniel H Solomon
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2017
Editorial: Tumor Necrosis Factor Antagonists: Killing Two Birds With One Biologic StoneJoan M Bathon, Jon T Giles, Daniel H Solomon
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Editorial: the vital role of randomized controlled trials in Arthritis & RheumatologyDaniel H Solomon, Michael E Weinblatt, Richard J Bucala
Rheumatology (Oxford, England)|December 23, 2019
Comment on: Comorbidity burden in axial spondyloarthritis: a cluster analysis: replySizheng Steven Zhao, Daniel H Solomon, Nicola J Goodson
Rheumatology (Oxford, England)|September 11, 2019
Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trialsKathleen M M Vanni, Houchen Lyu, Daniel H Solomon
Rheumatology International|April 19, 2018
Pseudogout among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition DiseaseSara K Tedeschi, Daniel H Solomon, Katherine P Liao
Arthritis Care & Research|June 1, 2019
Low-Dose Methotrexate and Mucocutaneous Adverse Events: Results of a Systematic Literature Review and Meta-Analysis of Randomized Controlled TrialsRiyana Lalani, Houchen Lyu, Kathleen Vanni, et al.
Hypertension (Dallas, Tex. : 1979)|July 1, 2004
Relationship between COX-2 specific inhibitors and hypertensionDaniel H Solomon, Sebastian Schneeweiss, Raisa Levin, et al.
Arthritis Care & Research|July 18, 2013
Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalinSeoyoung C Kim, Joan E Landon, Daniel H Solomon
Pageof 63